Back to the main directory
EarningsReview / Equity
- Handsets known, but product momentum to accelerate in H2 by BNP Paribas Exane
- Shouldn’t Consistency Yield A Better Multiple? by BNP Paribas Exane
- Qualcomm (QCOM US) by HSBC
- Beijer Ref - Buy/SEK 199: Proving them wrong by Nordea
- Separating for success by BNP Paribas Exane
- Hemnet Group - Buy/SEK 320 (275): We expect the strong trajectory to continue in 2024 by Nordea
- Waertsilae - Buy/EUR 15.30 (14.90): Aftermarket growth slowing, Marine outlook better by Nordea
- Ringkjoebing Landbobank - Buy/DKK 1,245 (1,200): Strong profit momentum to continue by Nordea
- A step in the right direction (+15 questions for management) by BNP Paribas Exane
- Novo Nordisk - Stepping on the Wegovy gas pedal by Danske Bank Equity Research
- ADIDAS AG: RDOS. PRELIMINARES 2023 (ANÁLISIS BANCO SABADELL) by Sabadell
- MedinCell - Ajustement de notre scenario pour tenir compte de la stratégie commerciale de Teva by MidCap Partners
- Figeac Aero - Objectifs 2023/24 et à moyen terme confirmés by MidCap Partners
- Synergie - Belle fin d’année à l’international by MidCap Partners
- Infotel - Investissements IT toujours au ralenti en bancaire by MidCap Partners
- INVEST SECURITIES – CARMAT : Succès de l'AK, marge de manœuvre renforcée - ACHAT vs SOUSCRIRE, OC 12€ vs 13€ by Invest Securities
- INVEST SECURITIES – AFFLUENT MEDICAL : Financement relais peu dilutif, visibilité mai 2024 - ACHAT, OC 3,5€ vs 2,6€ by Invest Securities
- HELLENiQ ENERGY - Shareholders reduce holding by Edison Investment Research
- Synergie - A Strong Year’s End Internationally by MidCap Partners
- Kaufman & Broad - Cash Machine! by MidCap Partners
- Obiz - 2023 Growth Clearly Exceeding Expectations by MidCap Partners
- Voltalia - Equity Story Intact After Publication of 2023 Revenue by MidCap Partners
- Mixed bag with MVF on-track but GM% expansion pushed out by BNP Paribas Exane
- 杭州银行（600926 CH） by HSBC
- LG Chemical (051910 KS) by HSBC